Going Virtual in the European Biopharmaceutical Industry: Conductors and Oxpeckers Make It

In the sector of biopharmaceuticals, the dominant business model remains the one of big pharmas: the vertical integration. However we currently observe in the European biotechnology industry the emergence of new business models. This article studies in particular the cases of an orchestra firm and a repurposing firm, both virtual all along the value chain… CONTINUE READING